Compound details
Karaviloside I
| Compound ID | CDAMM01187 |
|---|---|
| Common name | Karaviloside I | IUPAC name | 2-(hydroxymethyl)-6-[[7-methoxy-17-(6-methoxy-6-methylhept-4-en-2-yl)-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol |
| Molecular formula | C38H64O8 |
| Retention time | 11.24 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 649.465 | Theoretical mz | 649.467 |
| Error | 3.04 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.361 |
| Inchi key | YCUBHAWXGLKZIA-KMLPOZKONA-N |
|---|---|
| Smiles | OCC1OC(OC2CCC3C(=CC(OC)C4C3(C)CCC5(C)C(CCC45C)C(C)CC=CC(OC)(C)C)C2(C)C)C(O)C(O)C1O |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|